Bots, editor, reviewer, Administrators
13,951
edits
WikiJournalClub:Usable articles: Difference between revisions
Jump to navigation
Jump to search
WikiJournalClub:Usable articles (view source)
Revision as of 05:07, 3 September 2016
, 3 September 2016no edit summary
No edit summary |
No edit summary |
||
| Line 139: | Line 139: | ||
* [[ESCAPE]] (2005): PA catheters in acute HF management | * [[ESCAPE]] (2005): PA catheters in acute HF management | ||
* [[EVEREST-Outcomes]] (2007): Tolvaptan in acute HF in HFrEF | * [[EVEREST-Outcomes]] (2007): Tolvaptan in acute HF in HFrEF | ||
* [[HEARTMATE II]] (2009): Continuous-flow LVAD in heart failure | |||
* [[MADIT-CRT]] (2009): CRT in HFrEF with QRS ≥130 msec and mild symptoms | * [[MADIT-CRT]] (2009): CRT in HFrEF with QRS ≥130 msec and mild symptoms | ||
* [[MADIT-II]] (2002): ICD in post-MI patients with HFrEF | * [[MADIT-II]] (2002): ICD in post-MI patients with HFrEF | ||
| Line 144: | Line 145: | ||
* [[NEAT-HFpEF]] (2015): Nitrates for activity tolerance in HFpEF | * [[NEAT-HFpEF]] (2015): Nitrates for activity tolerance in HFpEF | ||
* [[PARADIGM-HF]] (2014): ARNI vs. enalapril in HFrEF | * [[PARADIGM-HF]] (2014): ARNI vs. enalapril in HFrEF | ||
* [[RAFT]] (2010): Addition of cardiac-resynchronization therapy to implantable cardioverter–defibrillator for mild-to-moderate heart failure | |||
* [[RALES]] (1999): Spironolactone in HFrEF | * [[RALES]] (1999): Spironolactone in HFrEF | ||
* [[SAVE]] (1992): Captopril in MI with LV dysfunction | * [[SAVE]] (1992): Captopril in MI with LV dysfunction | ||